46.98
Springworks Therapeutics Inc 주식(SWTX)의 최신 뉴스
SpringWorks Therapeutics (NASDAQ:SWTX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Assenagon Asset Management S.A. Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
SpringWorks Therapeutics (SWTX) Continues Strong Yearly Run, Showing Over 29% YTD Gain - Daily Chhattisgarh News
Biotech Stocks To ConsiderJune 16th - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
FNY Investment Advisers LLC Purchases New Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics Announces Merger with Merck KGaA - TipRanks
SpringWorks Merger Moves Forward with Regulatory Clearances By Investing.com - Investing.com India
SpringWorks Merger Moves Forward with Regulatory Clearances - Investing.com
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OPOF, PRA, SWTX, FLS on Behalf of Shareholders - ACCESS Newswire
HAPPY FATHER’S DAY and $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger: OPOF, PRA, SWTX and FLS - ACCESS Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders - GlobeNewswire Inc.
SpringWorks Therapeutics’ SWOT analysis: stock outlook amid Merck acquisition - Investing.com
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
SpringWorks Therapeutics, Inc. Stock Update: Steady Performance Amid Market Trends - Daily Chhattisgarh News
Best Biotech Stocks To Research – June 9th - Defense World
Best Growth Stocks To Follow Now – June 9th - Defense World
Squarepoint Ops LLC Cuts Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
88,995 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Bought by RFG Advisory LLC - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Top Growth Stocks To Follow Now – June 4th - Defense World
Best Biotech Stocks Worth Watching – June 4th - Defense World
(SWTX) Proactive Strategies - news.stocktradersdaily.com
SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc.SWTX - Business Wire
Nuveen Asset Management LLC Has $6.64 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
$HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - Benzinga
BNP Paribas Financial Markets Acquires Shares of 9,719 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Promising Growth Stocks To Research – May 28th - Defense World
ProShare Advisors LLC Acquires 5,503 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Deutsche Bank AG Purchases 19,540 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Merck, SpringWorks receive German antitrust approval for their deal - MLex
Palisades Investment Partners LLC Purchases 12,154 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Bank of America Corp DE Reduces Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Surged on Acquisition News - Insider Monkey
BNP Paribas Financial Markets Makes New $351,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease - Nasdaq
SpringWorks Gets CHMP Nod For Mirdametinib In Rare Disease - Barchart.com
142,300 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Bought by Zimmer Partners LP - MarketBeat
SpringWorks Therapeutics’ SWOT analysis: biotech stock faces acquisition challenges - Investing.com
Growth Stocks To Consider – May 23rd - Defense World
Growth Stocks To ConsiderMay 23rd - MarketBeat
(SWTX) Investment Analysis - news.stocktradersdaily.com
SpringWorks Therapeutics receives positive CHMP opinion for Mirdametinib for the treatment of adult and paediatric patients with NF1-PN | Health & Wellbeing | Lifestyle - The Phoenix Newspaper UK
자본화:
|
볼륨(24시간):